Windtree Therapeutics Stock Plunges Amid Nasdaq Delisting
The stock of Windtree Therapeutics has fallen by 77% after the Nasdaq began the process of delisting the company. The exchange cited a failure…
Biotech Windtree Secures $520M for BNB Treasury
Windtree Therapeutics, a biotechnology firm, has secured up to $520 million in new funding to significantly expand its BNB cryptocurrency…